Go to deals
Private Equity | Healthcare

Bionix has been recapitalized by Argosy Private Equity

Bionix, LLC has been recapitalized by Argosy Private Equity.

Bionix, headquartered in Toledo, Ohio, was founded in 1984 after identifying a need for disposable ear curettes. Since then, it has become a leading developer of innovative healthcare products for ear, nasal, and wound care applications, among others, that uniquely meet physicians’ needs. Backed by a strong patent portfolio, Bionix is a premium brand for innovative features and superior performance relative to low-cost commodity alternatives. The company manufactures its products in the USA and serves customers in every region of the world.

Argosy Private Equity is a lower middle-market private equity firm which invests in manufacturing and business services companies through management and leveraged buy-outs, recapitalizations, corporate divestitures, growth financings and generational transitions of family-owned businesses.

Oaklins’ team in Cleveland served as the exclusive financial advisor to Bionix.

Service
M&A sell-side
Parties

Talk to the deal team

 Andrew P. Male

Andrew P. Male

Managing Director

Cleveland, United States
Oaklins Citizens Capital Markets
 Savanna  Roberts

Savanna Roberts

Associate

Cleveland, United States
Oaklins Citizens Capital Markets

Related deals

VHZ Group has been acquired by Gilde Equity Management and VHZ Group’s management
Private Equity | Construction & Engineering Services

VHZ Group has been acquired by Gilde Equity Management and VHZ Group’s management

VHZ Group, the market leader in the Dutch B2B uPVC windows and doors market, has been acquired by Gilde Equity Management (GEM) together with the company’s management. With the acquisition, VHZ Group and GEM will be able to further expand on the company’s strategy and vision.

Learn more
ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners
Healthcare | TMT

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners

Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.

Learn more
esignatur has been acquired by Scrive
Private Equity | TMT

esignatur has been acquired by Scrive

esignatur has been acquired by Scrive, a portfolio company of Vitruvian Partners. esignatur and Scrive both specialize in digital signing solutions and complement each other with strong geographical and sector reach.

Learn more